首页> 外文期刊>Food Control >Occurrence of biogenic amines in beers from Chilean market
【24h】

Occurrence of biogenic amines in beers from Chilean market

机译:智利市场啤酒中存在生物胺

获取原文
获取原文并翻译 | 示例
           

摘要

The presence of tryptamine, phenylethylamine, putrescine, cadaverine, histamine, tyramine, spermidine and spermine was determined for the first time in beers commercialized in Chilean market. Dansylated amines were separated on a Zorbax-XDB C-18 column using a binary mobile phase composed of acetonitrile and 20 mmol L-1 ammonium formate, pH 5.5. Chromatographic conditions were optimized using an experimental design, and validation was carried out following ICH recommendations. Calibration data fitted a linear regression model with R-2 > 0.996. Repeatability (n = 6) and intermediate precision (n = 3) in matrix showed RSD values lower than 5.00% and 5.21%, respectively. Recoveries at three different concentrations ranged from 75.50 to 96.48%. The proposed method was applied to determine the biogenic amines content in 101 beer samples produced by macro- (n = 65) and microbreweries (n = 36) using low (n = 63) and high fermentations (n = 38). Biogenic amines content in beer samples ranged from 0.53 to 85.04 mg L-1, from which beers produced by microbreweries (19.13 16.92 mg L-1) showed a significant higher biogenic amines content (P = 0.0021) than beers produced by macrobreweries (9.65 +/- 4.50 mg L-1). Putrescine was the principal biogenic amine found in all kind of beers regardless origin, and the type of fermentation and brewery. Only 2 samples presented relevant levels of histamine and tyramine, but both below the limits reported by the European Food Safety Authority (EFSA). Thus, it can be concluded that beers" commercialized in Chile are not a serious toxicological risk (e.g. hypertensive crisis) regarding the type and content of biogenic amines. (C) 2016 Elsevier Ltd. All rights reserved.
机译:在智利市场上商业化的啤酒中首次确定存在色胺,苯乙胺,腐胺,尸胺,组胺,酪胺,亚精胺和亚精胺。使用由乙腈和20 mmol L-1甲酸铵(pH 5.5)组成的二元流动相,在Zorbax-XDB C-18色谱柱上分离丹酰化胺。使用实验设计优化了色谱条件,并按照ICH的建议进行了验证。校正数据拟合了R-2> 0.996的线性回归模型。基质中的重复性(n = 6)和中间精度(n = 3)分别显示RSD值低于5.00%和5.21%。三种不同浓度的回收率范围为75.50至96.48%。拟议的方法用于测定101个啤酒样品中的生物胺含量,其中101个啤酒样品由低发酵(n = 63)和高发酵度(n = 38)组成,其中大型啤酒厂(n = 65)和微型啤酒厂(n = 36)。啤酒样品中的生物胺含量在0.53至85.04 mg L-1之间,微型啤酒所产生的啤酒(19.13 16.92 mg L-1)的啤酒中生物胺含量(P = 0.0021)比大型啤酒所产生的啤酒(9.65 + /-4.50毫克L-1)。腐胺是各种啤酒中发现的主要生物胺,无论其来源,发酵和啤酒厂的类型如何。只有2个样品的组胺和酪胺含量较高,但均低于欧洲食品安全局(EFSA)报告的限量。因此,可以得出结论,在智利商业化生产的啤酒对于生物胺的种类和含量而言并不是严重的毒理学风险(例如高血压危机)。(C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号